‘Dead End’: Radical 20-Year Study Reveals Genetic Cloning Hits a Limit
On Mar. 25, 2026, researchers, led by scientists at the University of Yamanashi in Japan, cloned a single…
-
-
WHO Data Show Pertussis (Whooping Cough) Rising in Western Pacific and Europe
On Mar. 25, 2026, according to the latest data published by the World Health Organization (WHO), globally, 941,582…
-
Canine companions: revealing the genetic history of our first friends
On Mar. 24, 2026, researchers at the Francis Crick Institute report that the largest ancient DNA study of…
-
DNA in dirt is shaking up the study of human origins
On Mar. 24, 2026, a study published in Nature describes how researchers are pulling clues from genetic material…
-
UCB to Invest $2 Billion in Georgia, Establish First U.S. Manufacturing Facility
On Mar. 24, 2026, Governor Brian P. Kemp announced that global biopharmaceutical giant UCB, is planning a significant…
-
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
On Mar. 24, 2026, Pfizer and Valneva announced topline results from the Phase 3 VALOR “Vaccine Against Lyme…
-
New enzyme atlas rewrites decades of biology research
On Mar. 23, 2026, The Walter and Eliza Hall Institute of Medical Research (WEHI) researchers have led a…
-
Wilmington PharmaTech Launches $50 Million Expansion to Double U.S. Small‑Molecule API Manufacturing Capacity in Delaware
On Mar. 23, 2026, Wilmington PharmaTech, a leading U.S.-based research, development, and manufacturing organization (CRDMO) focused on complex…
-
Largest Animal Health Emergency in U.S. History Continues as HPAI Devastates Indiana
On Mar. 23, 2026, it was reported that since the beginning of March, highly pathogenic avian influenza has…
-
Novartis to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline for $3 Billion
On Mar. 20, 2026, Novartis announced an agreement with Synnovation Therapeutics, to acquire SNV4818, a pan-mutant‑selective PI3Kα inhibitor,…
-
NIH-awarded life scientist Shu Xiaokun abruptly shifts research from US to China
On Mar. 20, 2026, the South China Morning Post reported that celebrated scientist Shu Xiaokun, Ph.D. leaves prestigious…
-
Biotechnology | CDC | Infectious Disease | NIH | Vaccine | WHO
Danish university places hold on controversial U.S. CDC hepatitis B vaccine study in Guinea-Bissau
On Mar. 19, 2026, the University of Southern Denmark announced it has placed a “full hold” on a…
-
Biotechnology | Disease | FDA | Therapeutics
FDA approves new higher-dose version of Wegovy shots
On Mar. 19, 2026, The U.S. Food and Drug Administration approved a 7.2-milligram dose of Danish drugmaker Novo…
-
Biotechnology | CDC | Clinical Research | COVID-19 | Diagnostics | Genomics | Infectious Disease | Vaccine
CDC Reports Detection and Surveillance of New SARS-CoV-2 Variant BA.3.2
On Mar. 19, 2026, the U.S. Centers for Disease Control and Prevention announced that as of February 11,…
-
Agriculture | Artificial Intelligence | Biotechnology | Diagnostics | Environmental | FDA | Genomics | Imaging | Infectious Disease | Medical Device | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine | Veterinary | Women's Health
National survey of NIH-funded researchers shows precarious state of U.S. science — ‘This is like the Titanic’
On Mar. 19, 2026, a nationwide STAT survey of federally funded researchers reveals that, a year after Donald…
-
Biotechnology | Cardiology | Diagnostics | FDA | Neurology | NIH | Rare Disease | Therapeutics | Women's Health
NIH invests $150 million in human-based research to reduce use of animal models
On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…
-
New Genetic Risk Score Better Predicts Diabetes, Obesity and Downstream Complications
On Mar. 16, 2026, investigators from Mass General Brigham announce they have built metabolic polygenic risk scores (PRS) for predicting…
-
Biotechnology | Disease | Imaging | Neurology | Therapeutics
RNA barcodes enable high-speed mapping of connections in the brain
On Mar. 13, 2026, a research team lead by Boxuan Zhao, a professor of cell and developmental biology…
-
ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 Healthy and Cancer Donors
On Mar. 13, 2026, ImmunityBio announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a…
-
GSK’s RSV vaccine, Arexvy, approved in US for expanded age indication in adults aged 18–49 years at increased risk
On Mar. 13, 2026, GSK announced that the US Food and Drug Administration (FDA) has expanded the approved…
-
Stanley Family Foundation renews commitment to accelerate psychiatric research at Broad Institute
On Mar. 12, 2026, the Stanley Family Foundation renewed its commitment to psychiatric research at the Broad Institute,…
-
Biotechnology | Chemistry | Energy | Materials | Medicine
Failed experiment leads to surprise drug development breakthrough
On Mar. 12, 2026, scientists at the University of Cambridge announced they have developed a new way to…
-
Biotechnology | Diagnostics | Medical Device | Medicine | Neurology | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
Mass General Brigham Receives Transformative $50 Million Gift to Shape Future of Cancer Research
On Mar. 12, 2026, Mass General Brigham (MGB) announced it has received a $50 million gift that will…
-
USC study reveals differences in early Alzheimer’s brain markers across diverse populations
On Mar. 12, 2026, a team of researchers at the University of Southern California Mark and Mary Stevens…
-
Researchers Develop New Way to Safely Insert Gene-Sized DNA Into the Genome
On Mar. 11, 2026, taking a step towards developing genetic therapies at scale, researchers from Mass General Brigham…
-
FDA Launches New Adverse Event Monitoring System (AEMS)
On Mar. 11, 2026, the U.S. Food and Drug Administration (FDA) announced it is implementing the Adverse Event…
-
Dengue vaccine remains 80.5% effective against severe cases after five years
On Mar. 11, 2026, the tetravalent dengue vaccine, developed by the Butantan Institute in São Paulo, Brazil, with…
-
Blood Test Predicts Dementia in Women as Many as 25 Years Before Symptoms Begin
On Mar. 10, 2026, researchers from the University of California San Diego have found that a novel blood-based…
-
WHO releases first-ever implementation handbook to accelerate country action on hepatitis elimination
On Mar. 10, 2026, the World Health Organization (WHO) released landmark Consolidated guidance and implementation handbook on hepatitis…
-
New Study Exposes Hidden Alzheimer’s “Hot Spots” in Rural Maryland and What They Reveal About America’s Growing Healthcare Divide
On Mar. 8, 2026, a new statewide spatial analysis of Alzheimer’s disease and related dementias (ADRD) has uncovered…
